Differential subnetwork of chemokines/ cytokines in human, mouse, and rat brain cells after oxygen-glucose deprivation

Journal of Cerebral Blood Flow and Metabolism

Volumn 37, Issue 4, 2017, Pages 1425-1434

  Du, Yang ^a,b   Deng, Wenjun ^b   Wang, Zixing ^c   Ning, Mingming ^b   Zhang, Wei ^a   Zhou, Yiming ^b   Lo, Eng H ^b   Xing, Changhong ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Human; Inflammation; Mouse; Oxygen glucose deprivation; Rat

Indexed keywords

CD31 ANTIGEN; CHEMOKINE; FRACTALKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MICROTUBULE ASSOCIATED PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELIN BASIC PROTEIN; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR; GLUCOSE; INTERLEUKIN DERIVATIVE; OXYGEN;

ANIMAL CELL; ARTICLE; BRAIN ISCHEMIA; CELL DEATH; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; MICROGLIA; MOUSE; MTT ASSAY; NERVE CELL NETWORK; NEWBORN; NONHUMAN; OXYGEN GLUCOSE DEPRIVATION; PRIORITY JOURNAL; PROCEDURES CONCERNING CELLS; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REOXYGENATION; UPREGULATION; ANIMAL; ASTROCYTE; BRAIN; C57BL MOUSE; CELL CULTURE; CELL CULTURE TECHNIQUE; CYTOLOGY; GENE EXPRESSION; GENETICS; IMMUNOLOGY; METABOLISM; NERVE CELL; SPECIES DIFFERENCE; SPRAGUE DAWLEY RAT;

ANIMALS; ASTROCYTES; BRAIN; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CHEMOKINES; DOWN-REGULATION; GENE EXPRESSION; GLUCOSE; HUMANS; INTERLEUKINS; MICE, INBRED C57BL; MICROGLIA; NEURONS; OXYGEN; RATS, SPRAGUE-DAWLEY; SPECIES SPECIFICITY; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 85026326653     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1177/0271678X16656199     Document Type: Article

References (48)

1. Fisher M. Ensuring the future of clinical and basic stroke research. Stroke 2014; 45: 2493-2496.
2. Lo EH. 2013 Thomas Willis Award Lecture: causation and collaboration for stroke research. Stroke 2014; 45: 305-308.
3. Dowell RD. The similarity of gene expression between human and mouse tissues. Genome Biol 2011; 12: 101.
4. Liao BY and Zhang J. Evolutionary conservation of expression profiles between human and mouse orthologous genes. Mol Biol Evol 2006; 23: 530-540.
5. Prasad A, Kumar SS, Dessimoz C, et al. Global regulatory architecture of human, mouse and rat tissue transcriptomes. BMC Genom 2013; 14: 716.
6. Tsaparas P, Marino-Ramirez L, Bodenreider O, et al. Global similarity and local divergence in human and mouse gene co-expression networks. BMC Evol Biol 2006; 6: 70.
7. Yanai I, Graur D and Ophir R. Incongruent expression profiles between human and mouse orthologous genes suggest widespread neutral evolution of transcription control. Omics 2004; 8: 15-24.
8. Zhao S, Shetty J, Hou L, et al. Human, mouse, and rat genome large-scale rearrangements: stability versus speciation. Genome Res 2004; 14: 1851-1860.
9. Zheng-Bradley X, Rung J, Parkinson H, et al. Large scale comparison of global gene expression patterns in human and mouse. Genome Biol 2010; 11: R124.
10. Seok J, Warren HS, Cuenca AG, et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 2013; 110: 3507-3512.
11. Xing C, Lee S, Kim WJ, et al. Role of oxidative stress and caspase 3 in CD47-mediated neuronal cell death. J Neurochem 2009; 108: 430-436.
12. Xing C, Wang X, Cheng C, et al. Neuronal production of lipocalin-2 as a help-me signal for glial activation. Stroke 2014; 45: 2085-2092.
13. Xing C, Arai K, Park KP, et al. Induction of vascular endothelial growth factor and matrix metalloproteinase-9 via CD47 signaling in neurovascular cells. Neurochem Res 2010; 35: 1092-1097.
14. Gubern C, Hurtado O, Rodriguez R, et al. Validation of housekeeping genes for quantitative real-time PCR in invivo and in-vitro models of cerebral ischaemia. BMC Mol Biol 2009; 10: 57.
15. Foldager CB, Munir S, Ulrik-Vinther M, et al. Validation of suitable house keeping genes for hypoxia-cultured human chondrocytes. BMC Mol Biol 2009; 10: 94.
16. Thal SC, Wyschkon S, Pieter D, et al. Selection of endogenous control genes for normalization of gene expression analysis after experimental brain trauma in mice. J Neurotrauma 2008; 25: 785-794.
17. Byrnes KR, Fricke ST and Faden AI. Neuropathological differences between rats and mice after spinal cord injury. J Magn Reson Imag 2010; 32: 836-846.
18. Sroga JM, Jones TB, Kigerl KA, et al. Rats and mice exhibit distinct inflammatory reactions after spinal cord injury. J Comp Neurol 2003; 462: 223-240.
19. Schroeter M, Kury P and Jander S. Inflammatory gene expression in focal cortical brain ischemia: differences between rats and mice. Brain Res Mol Brain Res 2003; 117: 1-7.
20. Dirnagl U, Iadecola C and Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999; 22: 391-397.
21. Doll DN, Barr TL and Simpkins JW. Cytokines: their role in stroke and potential use as biomarkers and therapeutic targets. Aging Dis 2014; 5: 294-306.
22. Murray KN, Parry-Jones AR and Allan SM. Interleukin-1 and acute brain injury. Front Cell Neurosci 2015; 9: 18.
23. Barone FC, Arvin B, White RF, et al. Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke 1997; 28: 1233-1244.
24. Castillo J, Moro MA, Blanco M, et al. The release of tumor necrosis factor-alpha is associated with ischemic tolerance in human stroke. Ann Neurol 2003; 54: 811-819.
25. Suzuki S, Tanaka K and Suzuki N. Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects. J Cereb Blood Flow Metab 2009; 29: 464-479.
26. Ooboshi H, Ibayashi S, Shichita T, et al. Postischemic gene transfer of interleukin-10 protects against both focal and global brain ischemia. Circulation 2005; 111: 913-919.
27. Conductier G, Blondeau N, Guyon A, et al. The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases. J Neuroimmunol 2010; 224: 93-100.
28. Carr MW, Roth SJ, Luther E, et al. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci U S A 1994; 91: 3652-3656.
29. Sozzani S, Zhou D, Locati M, et al. Receptors and transduction pathways for monocyte chemotactic protein-2 and monocyte chemotactic protein-3. Similarities and differences with MCP-1. J Immunol 1994; 152: 3615-3622.
30. Mirabelli-Badenier M, Braunersreuther V, Viviani GL, et al. CC and CXC chemokines are pivotal mediators of cerebral injury in ischaemic stroke. Thromb Haemost 2011; 105: 409-420.
31. Romagnani P and Crescioli C. CXCL10: a candidate biomarker in transplantation. Clin Chim Acta 2012; 413: 1364-1373.
32. Campbell JD, Gangur V, Simons FE, et al. Allergic humans are hyporesponsive to a CXCR3 ligand-mediated Th1 immunity-promoting loop. Faseb J 2004; 18: 329-331.
33. Reaux-Le Goazigo A, Van Steenwinckel J, Rostene W, et al. Current status of chemokines in the adult CNS. Prog Neurobiol 2013; 104: 67-92.
34. Ransohoff RM. Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology. Immunity 2009; 31: 711-721.
35. Banisadr G, Gosselin RD, Mechighel P, et al. Highly regionalized neuronal expression of monocyte chemoattractant protein-1 (MCP-1/CCL2) in rat brain: evidence for its colocalization with neurotransmitters and neuropeptides. J Comp Neurol 2005; 489: 275-292.
36. Rostene W, Kitabgi P and Parsadaniantz SM. Chemokines: a new class of neuromodulator? Nat Rev Neurosci 2007; 8: 895-903.
37. Stumm R and Hollt V. CXC chemokine receptor 4 regulates neuronal migration and axonal pathfinding in the developing nervous system: implications for neuronal regeneration in the adult brain. J Mol Endocrinol 2007; 38: 377-382.
38. Birgersdotter A, Sandberg R and Ernberg I. Gene expression perturbation in vitro-a growing case for threedimensional (3D) culture systems. Semin Cancer Biol 2005; 15: 405-412.
39. Sandberg R and Ernberg I. The molecular portrait of in vitro growth by meta-analysis of gene-expression profiles. Genome Biol 2005; 6: R65.
40. Leite J, Hespanhol R and Buchpiguel CA. Molecular imaging in genetics. Neuroimaging Clin N Am 2015; 25: 17-29.
41. Stamova B, Xu H, Jickling G, et al. Gene expression profiling of blood for the prediction of ischemic stroke. Stroke 2010; 41: 2171-2177.
42. Tang Y, Lu A, Aronow BJ, et al. Blood genomic responses differ after stroke, seizures, hypoglycemia, and hypoxia: blood genomic fingerprints of disease. Ann Neurol 2001; 50: 699-707.
43. Tang Y, Xu H, Du X, et al. Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study. J Cereb Blood Flow Metab 2006; 26: 1089-1102.
44. Battle A, Khan Z, Wang SH, et al. Genomic variation. Impact of regulatory variation from RNA to protein. Science 2015; 347: 664-667.
45. Jovanovic M, Rooney MS, Mertins P, et al. Immunogenetics. Dynamic profiling of the protein life cycle in response to pathogens. Science 2015; 347: 1259038.
46. Li JJ, Bickel PJ and Biggin MD. System wide analyses have underestimated protein abundances and the importance of transcription in mammals. PeerJ 2014; 2: e270.
47. Li JJ and Biggin MD. Gene expression. Statistics requantitates the central dogma. Science 2015; 347: 1066-1067.
48. Dirnagl U and Endres M. Found in translation: preclinical stroke research predicts human pathophysiology, clinical phenotypes, and therapeutic outcomes. Stroke 2014; 45: 1510-1518.